We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chemours (CC) Gains As Market Dips: What You Should Know
Read MoreHide Full Article
Chemours (CC - Free Report) closed the most recent trading day at $25.88, moving +1.61% from the previous trading session. This move outpaced the S&P 500's daily loss of 0.43%. Elsewhere, the Dow lost 0.34%, while the tech-heavy Nasdaq lost 0.62%.
Heading into today, shares of the chemical company had lost 29.33% over the past month, lagging the Basic Materials sector's gain of 4.32% and the S&P 500's loss of 6.57% in that time.
Wall Street will be looking for positivity from Chemours as it approaches its next earnings report date. On that day, Chemours is projected to report earnings of $0.90 per share, which would represent year-over-year growth of 26.76%. Meanwhile, our latest consensus estimate is calling for revenue of $1.54 billion, up 7.04% from the prior-year quarter.
CC's full-year Zacks Consensus Estimates are calling for earnings of $4.51 per share and revenue of $6.67 billion. These results would represent year-over-year changes of +12.75% and +5.15%, respectively.
Investors should also note any recent changes to analyst estimates for Chemours. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 3.8% higher. Chemours is currently sporting a Zacks Rank of #3 (Hold).
Looking at its valuation, Chemours is holding a Forward P/E ratio of 5.65. This represents a discount compared to its industry's average Forward P/E of 11.54.
Also, we should mention that CC has a PEG ratio of 0.44. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Chemical - Diversified stocks are, on average, holding a PEG ratio of 0.93 based on yesterday's closing prices.
The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 154, putting it in the bottom 40% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow CC in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Chemours (CC) Gains As Market Dips: What You Should Know
Chemours (CC - Free Report) closed the most recent trading day at $25.88, moving +1.61% from the previous trading session. This move outpaced the S&P 500's daily loss of 0.43%. Elsewhere, the Dow lost 0.34%, while the tech-heavy Nasdaq lost 0.62%.
Heading into today, shares of the chemical company had lost 29.33% over the past month, lagging the Basic Materials sector's gain of 4.32% and the S&P 500's loss of 6.57% in that time.
Wall Street will be looking for positivity from Chemours as it approaches its next earnings report date. On that day, Chemours is projected to report earnings of $0.90 per share, which would represent year-over-year growth of 26.76%. Meanwhile, our latest consensus estimate is calling for revenue of $1.54 billion, up 7.04% from the prior-year quarter.
CC's full-year Zacks Consensus Estimates are calling for earnings of $4.51 per share and revenue of $6.67 billion. These results would represent year-over-year changes of +12.75% and +5.15%, respectively.
Investors should also note any recent changes to analyst estimates for Chemours. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 3.8% higher. Chemours is currently sporting a Zacks Rank of #3 (Hold).
Looking at its valuation, Chemours is holding a Forward P/E ratio of 5.65. This represents a discount compared to its industry's average Forward P/E of 11.54.
Also, we should mention that CC has a PEG ratio of 0.44. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Chemical - Diversified stocks are, on average, holding a PEG ratio of 0.93 based on yesterday's closing prices.
The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 154, putting it in the bottom 40% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow CC in the coming trading sessions, be sure to utilize Zacks.com.